ICES

Last updated
ICES
Company typeNot-for-profit corporation
Industry
Founded1992
Founder
Headquarters
Toronto, Ontario, Canada
Key people
Michael Schull, President and CEO
Products
Number of employees
400+
Website http://www.ices.on.ca

ICES (formerly known as the Institute for Clinical Evaluative Sciences) is an independent, non-profit corporation that applies the study of health informatics for health services research and population-wide health outcomes research in Ontario, Canada, using data collected through the routine administration of Ontario's system of publicly funded health care.  

Contents

ICES scientists have secure access to Ontario's health administrative data. ICES research teams produce peer-reviewed scientific journal articles, as well as reports and atlases to assist health care providers, government planners and policy makers in improving population health through the advancement of evidence-based practice and health policy.

ICES was established in 1992 and is governed by a board of directors. ICES receives core funding from the Ontario Ministry of Health and Long-Term Care (MOHLTC). In addition, ICES faculty and staff receive peer-reviewed grants from federal funding agencies such as the Canadian Institutes of Health Research, and project-specific funds from provincial and national organizations. [1]

ICES' central location is on the campus of Sunnybrook Health Sciences Centre in Toronto, with satellite locations in Kingston, Ontario, London, Ontario, Hamilton, Ontario and Sudbury, Ontario. [2]

Research programs

ICES research is distributed across eight health areas: [3]

  1. Cancer
  2. Cardiovascular
  3. Chronic Disease and Pharmacotherapy
  4. Kidney, Dialysis and Transplantation
  5. Life Stage
  6. Mental Health and Addictions
  7. Populations and Public Health
  8. Primary Care and Health Systems

History

In the early 1990s, the Government of Ontario identified a growing need for evidence on health system performance in Ontario, in order to ensure the quality and efficiency of health services being provided. [4] Dr. David Naylor and Dr. Jack Williams proposed to provincial health officials the creation of a new research institute that would securely analyse the administrative data routinely collected by the government through the Ontario Health Insurance Plan (OHIP), in order to produce population-based evidence.

ICES was launched in April 1992, with Naylor as the founding chief executive officer. [4]

Privacy and security

ICES is designated as a "prescribed entity" in Ontario under the Personal Health Information Protection Act (PHIPA). Under Section 45 of PHIPA, this designation allows ICES to collect and use administrative data for the purposes of monitoring and evaluating the provincial health system. [5] To be eligible to collect and use information under this authority, an organization must receive the approval of the Information and Privacy Commissioner of Ontario (the IPC), which must find that the organization is equipped to protect it. All ICES policies, practices and procedures for using data are reviewed and approved by the IPC every three years. [6]

Methodology and data holdings

The ICES data repository consists of patient-level, coded and linkable health records. It includes publicly funded administrative health services records for the Ontario population eligible for universal health coverage since 1986, within Ontario's population of 14.7 million (as of 2019). [7] Through partnerships, the data repository also securely links data from a variety of health surveys and registries. [8] By linking the different data sets together using anonymous numeric unique identifiers, ICES scientists track different aspects of health service use and patient outcomes over time and across the province. [9]

Examples of research impact

  1. A 1997 ICES study [10] led by Dr. Donald Redelmeier and published in the New England Journal of Medicine on the links between mobile phone use and motor vehicle collisions helped lay the groundwork for legislation banning driver cell phone use in Ontario and many other jurisdictions. [11]
  2. A 2004 ICES study [12] led by Dr. Muhammad Mamdani published in The Lancet found that of 45,000 Ontario seniors prescribed rofecoxib, 80% had an increase in hospital admissions for heart failure, while patients using other NSAIDs had a 40% increase. Although the absolute risk for heart failure was less than 1%, this finding was significant, given that more than 1 in 5 Ontario seniors were taking these medications. Vioxx was withdrawn from the market later that year. [13]
  3. A 2006 ICES study [14] led by Dr. Laura Park- Wyllie showed that gatifloxacin, a commonly prescribed antibiotic marketed as Tequin, could cause potentially life-threatening blood sugar abnormalities. The investigation showed that patients treated for low blood sugar levels were more than four times as likely to have received gatifloxacin as other common antibiotics, while those hospitalized with high blood sugar levels were nearly 17 times as likely to have been treated with the medication. Health Canada issued a warning [15] shortly after the study appeared in the New England Journal of Medicine, and soon after, the drug's manufacturer announced it was halting production. [16]
  4. ICES research into the impact of mandatory reporting on reducing hospital-acquired Clostridioides difficile infections led by Dr. Nick Daneman [17] has influenced Ontario's MOHLTC policies on mandatory hospital reporting of quality improvement targets. [18]
  5. A 2013 ICES study led by Thérèse Stukel identified nearly 80 informal multispecialty physician networks that formed the theoretical basis for the Ontario Community Health Links initiative currently underway for managing care for patients with complex conditions. The concept was cited as a model for using big data in the public interest in the 2015 Government of Canada "Report of the Advisory Panel on Healthcare Innovation" led by Dr. David Naylor. [19]
  6. Work led by ICES chief science officer Astrid Guttmann in 2015 showed that the number of children and youth being treated for concussion in Ontario had risen sharply during 2003–2011. [20] Concern with these findings helped pave the way for the implementation of "Rowan's Law," requiring measures be taken to prevent and mitigate head injuries due to participation in youth sports. [21]
  7. The 2015 ICES research report "Brain Disorders in Ontario: Prevalence, Incidence and Costs from Health Administrative Data" produced in collaboration with the Ontario Brain Institute [22] is being used in 2016 to plan Ontario's Dementia Strategy. [23]
  8. A 2015 ICES Western study led by Dr. Amit Garg and published in the New England Journal of Medicine showed the feasibility of a new technique to assess risk in living kidney donor candidates, which showed that some donors are unnecessarily excluded as donors for kidney transplantation due to older age or comorbidities. The findings form a framework for the new international clinical practice guidelines [24] in living kidney donation and a risk assessment tool [25] that is being used with donor candidates in Ontario as part of the informed consent process.
  9. Due to a rapid rise in the number of research studies conducted using routinely collected health data, ICES researchers were part of an international committee of researchers who published reporting guidelines called "RECORD" for all observational studies conducted using health data, which are applicable to research using health administrative data, electronic health records, registries, and other data sources. [26] RECORD has been endorsed and implemented by over 15 journals since its publication in October 2015, including the PLoS group of journals, JAMA, The BMJ, and CMAJ. [27]

See also

Related Research Articles

<span class="mw-page-title-main">Organ donation</span> Process of voluntarily giving away organs

Organ donation is the process when a person authorizes an organ of their own to be removed and transplanted to another person, legally, either by consent while the donor is alive, through a legal authorization for deceased donation made prior to death, or for deceased donations through the authorization by the legal next of kin.

<span class="mw-page-title-main">Organ transplantation</span> Medical procedure in which an organ is removed from one body and placed in the body of a recipient

Organ transplantation is a medical procedure in which an organ is removed from one body and placed in the body of a recipient, to replace a damaged or missing organ. The donor and recipient may be at the same location, or organs may be transported from a donor site to another location. Organs and/or tissues that are transplanted within the same person's body are called autografts. Transplants that are recently performed between two subjects of the same species are called allografts. Allografts can either be from a living or cadaveric source.

Prior to the introduction of brain death into law in the mid to late 1970s, all organ transplants from cadaveric donors came from non-heart-beating donors (NHBDs).

<span class="mw-page-title-main">Comparison of the healthcare systems in Canada and the United States</span> Healthcare system comparison

A comparison of the healthcare systems in Canada and the United States is often made by government, public health and public policy analysts. The two countries had similar healthcare systems before Canada changed its system in the 1960s and 1970s. The United States spends much more money on healthcare than Canada, on both a per-capita basis and as a percentage of GDP. In 2006, per-capita spending for health care in Canada was US$3,678; in the U.S., US$6,714. The U.S. spent 15.3% of GDP on healthcare in that year; Canada spent 10.0%. In 2006, 70% of healthcare spending in Canada was financed by government, versus 46% in the United States. Total government spending per capita in the U.S. on healthcare was 23% higher than Canadian government spending. U.S. government expenditure on healthcare was just under 83% of total Canadian spending.

<span class="mw-page-title-main">Healthcare in Canada</span>

Healthcare in Canada is delivered through the provincial and territorial systems of publicly funded health care, informally called Medicare. It is guided by the provisions of the Canada Health Act of 1984, and is universal. The 2002 Royal Commission, known as the Romanow Report, revealed that Canadians consider universal access to publicly funded health services as a "fundamental value that ensures national health care insurance for everyone wherever they live in the country."

<span class="mw-page-title-main">The Ottawa Hospital</span> Hospital in Ontario, Canada

The Ottawa Hospital is a hospital system in Ottawa, Ontario, Canada. The system was formed through the merger of the former Grace Hospital, Ottawa Riverside Hospital, Ottawa General Hospital and Ottawa Civic Hospital. The system is affiliated with the University of Ottawa, and its three campuses are all non-profit, public teaching hospitals.

<span class="mw-page-title-main">Kidney transplantation</span> Medical procedure

Kidney transplant or renal transplant is the organ transplant of a kidney into a patient with end-stage kidney disease (ESRD). Kidney transplant is typically classified as deceased-donor or living-donor transplantation depending on the source of the donor organ. Living-donor kidney transplants are further characterized as genetically related (living-related) or non-related (living-unrelated) transplants, depending on whether a biological relationship exists between the donor and recipient. The first successful kidney transplant was performed in 1954 by a team including Joseph Murray, the recipient's surgeon, and Hartwell Harrison, surgeon for the donor. Murray was awarded a Nobel Prize in Physiology or Medicine in 1990 for this and other work. In 2018, an estimated 95,479 kidney transplants were performed worldwide, 36% of which came from living donors.

<span class="mw-page-title-main">David Naylor</span>

Christopher David Naylor is a Canadian physician, medical researcher and former president of the University of Toronto. He is ICES scientist emeritus and founding CEO. In 2016, he was inducted into the Canadian Medical Hall of Fame.

<span class="mw-page-title-main">Canadian Blood Services</span> Canadian health non-profit

Canadian Blood Services is a non-profit charitable organization that is independent from the Canadian government. The Canadian Blood Services was established as Canada's blood authority in all provinces and territories except for Quebec in 1998. The federal, provincial and territorial governments created the Canadian Blood Services through a memorandum of understanding. Canadian Blood Services is funded mainly through the provincial and territorial governments.

Dr. A. M. James Shapiro is a British-Canadian surgeon best known for leading the clinical team that developed the Edmonton Protocol – an islet transplant procedure for the treatment of type 1 diabetes. Dr. Shapiro is Professor of Surgery, Medicine, and Surgical Oncology at the University of Alberta and the Director of the Clinical Islet Transplant Program and the Living Donor Liver Transplant Program with Alberta Health Services.

<span class="mw-page-title-main">Gatifloxacin</span> Chemical compound

Gatifloxacin is an antibiotic of the fourth-generation fluoroquinolone family, that like other members of that family, inhibits the bacterial enzymes DNA gyrase and topoisomerase IV.

Organ trade is the trading of human organs, tissues, or other body products, usually for transplantation. According to the World Health Organization (WHO), organ trade is a commercial transplantation where there is a profit, or transplantations that occur outside of national medical systems. There is a global need or demand for healthy body parts for transplantation, which exceeds the numbers available.

<span class="mw-page-title-main">Vladimir Hachinski</span> Canadian clinical neuroscientist

Vladimir Hachinski is a Canadian clinical neuroscientist and researcher based at the Schulich School of Medicine and Dentistry at Western University. He is also a Senior Scientist at London's Robarts Research Institute. His research pertains in the greatest part to stroke and dementia, the interactions between them and their joint prevention through holistic brain health promotion. He and John W. Norris helped to establish the world's first successful stroke unit at Sunnybrook Hospital in Toronto, and, by extension, helped cement stroke units as the standard of care for stroke patients everywhere. He discovered that the control of the heart by the brain is asymmetric, the fight/flight (sympathetic) response being controlled by the right hemisphere and the rest and digest (parasympathetic) response being controlled by the left hemisphere and damage to one key component can lead to heart irregularities and sudden death. This discovery has added fundamental knowledge to how the brain controls the heart and blood pressure and lays the foundation for helping prevent sudden death.

Kidney paired donation (KPD), or paired exchange, is an approach to living donor kidney transplantation where patients with incompatible donors swap kidneys to receive a compatible kidney. KPD is used in situations where a potential donor is incompatible. Because better donor HLA and age matching are correlated with lower lifetime mortality and longer lasting kidney transplants, many compatible pairs are also participating in swaps to find better matched kidneys. In the United States, the National Kidney Registry organizes the majority of U.S. KPD transplants, including the largest swaps. The first large swap was a 60 participant chain in 2012 that appeared on the front page of the New York Times and the second, even larger swap, included 70 participants and was completed in 2014. Other KPD programs in the U.S. include the UNOS program, which was launched in 2010 and completed its 100th KPD transplant in 2014, and the Alliance for Paired Donation.

<span class="mw-page-title-main">Nancy Baxter</span> Canadian surgeon and researcher

Nancy Baxter is a Canadian surgeon who is a professor and Deputy Executive Dean of the Faculty of Medicine and Health, University of Sydney. She was Head of Melbourne University's School of Population and Global Health from 2020 to 2024 and continues to maintain her appointment as Professor of Surgery in the Department of Surgery and the Institute of Health Policy, Management and Evaluation at the University of Toronto. She is a scientist with the Li Ka Shing Knowledge Institute and is a senior scientist in the Cancer Theme Group with the Institute for Clinical Evaluative Sciences (ICES). Baxter has board certifications through the American Board of Surgery (2000) and the American Board of Colon and Rectal Surgery (2002). She is a Fellow of the American College of Surgeons, the Royal College of Physicians and Surgeons of Canada, and the American Society of Clinical Oncology.

Allison Joan McGeer is a Canadian infectious disease specialist in the Sinai Health System, and a professor in the Department of Laboratory Medicine and Pathobiology at the University of Toronto. She also appointed at the Dalla Lana School of Public Health and a Senior Clinician Scientist at the Lunenfeld-Tanenbaum Research Institute, and is a partner of the National Collaborating Centre for Infectious Diseases. McGeer has led investigations into the severe acute respiratory syndrome outbreak in Toronto and worked alongside Donald Low. During the COVID-19 pandemic, McGeer has studied how SARS-CoV-2 survives in the air and has served on several provincial committees advising aspects of the Government of Ontario's pandemic response.

Abida Sophie Jamal is a Canadian endocrinologist and former osteoporosis researcher who was at the centre of a scientific misconduct case in the mid-to-late 2010s. Jamal published a high-profile paper suggesting that the heart medication nitroglycerin was a treatment for osteoporosis, and was later demonstrated to have misrepresented her results. She received a lifetime ban from receiving funding from the Canadian Institutes of Health Research and was named directly in their disclosure report, becoming the first person mentioned by name by the institute for scientific misconduct. Jamal was later stripped of her medical license for two years, regaining it in a controversial 3–2 decision.

Adeera Levin is a Canadian Professor of Medicine, and is head of the Division of Nephrology at University of British Columbia.

Anna Banerji M.D., O. Ont. is a Toronto infectious disease doctor, tropical disease specialist, pediatrician, public health specialist, academic, and activist. She is the founder and chair of both the North American Refugee Health Conference in Canada and the Indigenous Health Conference, and the co-founder of the Society of Refugee Healthcare Providers. She was awarded the Dr Peter Bryce Henderson for her advocacy for Indigenous children.

Catharine Isobel Whiteside is a Canadian physician and medical researcher. She is Director, Strategic Partnerships of Diabetes Action Canada and Chair of the board of the Banting Research Foundation. Whiteside is the former Dean of the Faculty of Medicine at the University of Toronto.

References

  1. ↑ "About ICES". www.ices.on.ca. Retrieved 2016-10-12.
  2. ↑ "ICES Contacts & Locations". www.ices.on.ca. Archived from the original on 2019-12-30. Retrieved 2020-02-10.
  3. ↑ "Research Programs". www.ices.on.ca. Retrieved 2020-02-10.
  4. 1 2 Dolan, Doug; Grainger, James; MacCallum, Nancy; Creatura, Deborah; Shiller, Jacqueline Forrester and Susan (2012-10-29). "The Institute for Clinical Evaluative Sciences: 20 Years and Counting". Healthcare Quarterly. 15 (4): 19–21. doi: 10.12927/hcq.2012.23194 . PMID   23803399.
  5. ↑ "Law Document English View". Ontario.ca. 2014-07-24. Retrieved 2016-10-12.
  6. ↑ frank@v51.com. "Institute for Clinical Evaluative Sciences Letter, 2005 - IPC". IPC. Retrieved 2016-10-12.{{cite web}}: CS1 maint: numeric names: authors list (link)
  7. ↑ "Ontario Fact Sheet". Ontario Ministry of Finance. October 2019. Retrieved 2020-02-10.
  8. ↑ "ICES Data". www.ices.on.ca. Retrieved 2016-10-12.
  9. ↑ "Working with ICES Data". www.ices.on.ca. Retrieved 2016-10-12.
  10. ↑ Redelmeier, D. A.; Tibshirani, R. J. (1997-02-13). "Association between cellular-telephone calls and motor vehicle collisions". The New England Journal of Medicine. 336 (7): 453–458. doi: 10.1056/NEJM199702133360701 . ISSN   0028-4793. PMID   9017937.
  11. ↑ McCartt, Anne T.; Kidd, David G.; Teoh, Eric R. (2016-10-12). "Driver Cellphone and Texting Bans in the United States: Evidence of Effectiveness". Annals of Advances in Automotive Medicine. 58: 99–114. ISSN   1943-2461. PMC   4001674 . PMID   24776230.
  12. ↑ Mamdani, Muhammad; Juurlink, David N.; Lee, Douglas S.; Rochon, Paula A.; Kopp, Alex; Naglie, Gary; Austin, Peter C.; Laupacis, Andreas; Stukel, Thérèse A. (2004-05-29). "Cyclo-oxygenase-2 inhibitors versus non-selective non-steroidal anti-inflammatory drugs and congestive heart failure outcomes in elderly patients: a population-based cohort study". Lancet. 363 (9423): 1751–1756. doi:10.1016/S0140-6736(04)16299-5. ISSN   1474-547X. PMID   15172772. S2CID   19098525.
  13. ↑ "Muhammad Mamdani, 39: helps Canada make drug decisions". The Globe and Mail. Retrieved 2016-10-12.
  14. ↑ Park-Wyllie, Laura Y.; Juurlink, David N.; Kopp, Alexander; Shah, Baiju R.; Stukel, Thérèse A.; Stumpo, Carmine; Dresser, Linda; Low, Donald E.; Mamdani, Muhammad M. (2006-03-30). "Outpatient Gatifloxacin Therapy and Dysglycemia in Older Adults" (PDF). New England Journal of Medicine. 354 (13): 1352–1361. doi:10.1056/NEJMoa055191. hdl: 1807/16915 . ISSN   0028-4793. PMID   16510739.
  15. ↑ "Update regarding the association of Tequin (gatifloxacin) with serious hypoglycemia and hyperglycemia". Health Canada. May 17, 2006. Retrieved 2016-10-12.
  16. ↑ "Drug Company Taking Tequin Off Market". SF Gate. 2007-11-25. Archived from the original on 2007-11-25. Retrieved 2016-10-12.{{cite web}}: CS1 maint: bot: original URL status unknown (link)
  17. ↑ Daneman, N; Stukel, TA; Ma, X; Vermeulen, M; Guttmann, A (2012-07-17). "Reduction in Clostridium difficile Infection Rates after Mandatory Hospital Public Reporting". PLOS Medicine. 9 (7): e1001268. doi: 10.1371/journal.pmed.1001268 . PMC   3398960 . PMID   22815656.
  18. ↑ "Hospital C. difficile rates decline with mandatory reporting". CBC News. Retrieved 2016-10-12.
  19. ↑ Naylor, D (July 2015). "Report of the Advisory Panel on Healthcare Innovation". Government of Canada. Retrieved 2016-10-12.
  20. ↑ "More Ontario children, youth being treated for concussions: study". CTVNews. Retrieved 2016-10-12.
  21. ↑ "Rowan's Law Advisory Committee Act, 2016". Legislative Assembly of Ontario. Archived from the original on 2017-01-23. Retrieved 2016-10-12.
  22. ↑ "Brain Disorders in Ontario: Prevalence, Incidence and Costs from Health Administrative Data". www.ices.on.ca. Retrieved 2016-10-12.
  23. ↑ "Developing Ontario's Dementia Strategy: Discussion Paper". Government of Ontario. 2016-09-21. Retrieved 2016-10-12.
  24. ↑ Richardson, Robert; Connelly, Maureen; Dipchand, Christine; Garg, Amit X.; Ghanekar, Anand; Houde, Isabelle; Johnston, Olwyn; Mainra, Rahul; McCarrell, Ruth; Mueller, Thomas; Nickerson, Peter; Pippy, Christine; Storsley, Leroy; Tinckam, Kathryn; Wright, Linda; Yilmaz, Serdar; Landsberg, David; Protocols Working Group of the Canadian Blood Services' Living Donation Advisory Committee (2015). "Kidney Paired Donation Protocol for Participating Donors 2014". Transplantation. 99 (10 Suppl 1): S1–S88. doi: 10.1097/TP.0000000000000918 . PMID   26425842.
  25. ↑ "ESRD Risk Tool". www.transplantmodels.com. Retrieved 2016-10-12.
  26. ↑ Benchimol, Eric I.; Smeeth, Liam; Guttmann, Astrid; Harron, Katie; Moher, David; Petersen, Irene; Sørensen, Henrik T.; von Elm, Erik; Langan, Sinéad M. (2015-10-01). "The REporting of studies Conducted using Observational Routinely-collected health Data (RECORD) statement". PLOS Medicine. 12 (10): e1001885. doi: 10.1371/journal.pmed.1001885 . ISSN   1549-1676. PMC   4595218 . PMID   26440803.
  27. ↑ "RECORD Endorsements". record-statement.org. Retrieved 2016-10-12.
This page is based on this Wikipedia article
Text is available under the CC BY-SA 4.0 license; additional terms may apply.
Images, videos and audio are available under their respective licenses.